Cardiovascular Side Effects of Tyrosine Kinase Inhibitor Ibrutinib (Imbruvica) and Interaction With Direct Oral Anticoagulant

Creator(s)

Muhammad Khalid, Quillen-Dishner College of MedicineFollow
Furqan Khattak, Quillen-Dishner College of Medicine
Vijay Ramu, Quillen-Dishner College of MedicineFollow

Document Type

Letter

Publication Date

1-1-2018

Citation Information

Khalid, Muhammad; Khattak, Furqan; and Ramu, Vijay. 2018. Cardiovascular Side Effects of Tyrosine Kinase Inhibitor Ibrutinib (Imbruvica) and Interaction With Direct Oral Anticoagulant. American Journal of Therapeutics. Vol.25(6). E768-E769. https://doi.org/10.1097/MJT.0000000000000775 PMID: 29916856 ISSN: 1075-2765